A special double-episode of New Insight with Veeral Sheth, MD features a well-rounded conversation on all things ophthalmology with returning guest David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida, as well as first-time guest Roger Goldberg, MD, a vitreoretinal surgeon at Bay Area Retina Associates.



The trio of retina specialists discuss recent conference news, the anniversary of a landmark agent, and what’s to come in 2024 for the specialty.



Episode Highlights:

0:00 Introduction

1:25 Entering 2024

7:34 The importance of treatment efficacy

12:09 Re-engaging GA treatment

15:05 Comparing aflibercept 8 mg and faricimab

23:00 Real-world data sets

26:30 What’s to come in 2024

27:45 Intravitreal gene therapies

31:00 Port delivery system

36:00 Wrapping-up 



Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.